LU79423A1 - Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline - Google Patents

Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline

Info

Publication number
LU79423A1
LU79423A1 LU79423A LU79423A LU79423A1 LU 79423 A1 LU79423 A1 LU 79423A1 LU 79423 A LU79423 A LU 79423A LU 79423 A LU79423 A LU 79423A LU 79423 A1 LU79423 A1 LU 79423A1
Authority
LU
Luxembourg
Prior art keywords
pharmaceutical compositions
microcrystalline cellulose
compositions containing
preparing pharmaceutical
excipient based
Prior art date
Application number
LU79423A
Other languages
English (en)
Inventor
K Takeo
T Aoyagi
A Tamada
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4154577A external-priority patent/JPS53127553A/ja
Priority claimed from JP8254877A external-priority patent/JPS5420126A/ja
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of LU79423A1 publication Critical patent/LU79423A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU79423A 1977-04-13 1978-04-12 Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline LU79423A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4154577A JPS53127553A (en) 1977-04-13 1977-04-13 Vehicle
JP8254877A JPS5420126A (en) 1977-07-12 1977-07-12 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
LU79423A1 true LU79423A1 (fr) 1978-11-28

Family

ID=26381183

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79423A LU79423A1 (fr) 1977-04-13 1978-04-12 Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline

Country Status (11)

Country Link
US (1) US4159345A (fr)
AU (1) AU508480B2 (fr)
DE (1) DE2816055A1 (fr)
DK (1) DK159978A (fr)
FR (1) FR2387040A1 (fr)
GB (1) GB1603533A (fr)
IE (1) IE46720B1 (fr)
IT (1) IT1095577B (fr)
LU (1) LU79423A1 (fr)
NL (1) NL7803869A (fr)
PH (2) PH14128A (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (fr) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Procede de production d'un compose pharmaceutique a liberation continue sous forme solide
WO1981002521A1 (fr) * 1980-03-10 1981-09-17 Mendell Co Inc Edward Composition de vehicule pharmaceutique et son procede de production
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
EP0452862B1 (fr) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Noyaux des germes sphériques, granules sphériques et procédé de leur préparation
JP2542122B2 (ja) * 1990-04-18 1996-10-09 旭化成工業株式会社 球状核、球形顆粒およびその製造方法
DE4113044A1 (de) * 1990-10-09 1992-05-21 Degussa Zahnpflegemittel
FR2671970B1 (fr) * 1991-01-30 1995-06-23 Wellcome Found Comprimes dispersables dans l'eau.
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
TW260612B (fr) * 1993-01-05 1995-10-21 Asahi Chemical Ind
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5665414A (en) * 1995-04-06 1997-09-09 Edward Mendell Co., Inc. Cellulosic materials for incorporation into food products and methods of making same
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6210801B1 (en) 1996-08-23 2001-04-03 Weyerhaeuser Company Lyocell fibers, and compositions for making same
US6331354B1 (en) 1996-08-23 2001-12-18 Weyerhaeuser Company Alkaline pulp having low average degree of polymerization values and method of producing the same
US6471727B2 (en) 1996-08-23 2002-10-29 Weyerhaeuser Company Lyocell fibers, and compositions for making the same
US6306334B1 (en) 1996-08-23 2001-10-23 The Weyerhaeuser Company Process for melt blowing continuous lyocell fibers
JP3718341B2 (ja) * 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
US6232351B1 (en) 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US6773648B2 (en) 1998-11-03 2004-08-10 Weyerhaeuser Company Meltblown process with mechanical attenuation
US7056531B1 (en) * 2000-05-04 2006-06-06 Nature's Way Products, Inc. Sustained release compositions for orally administered substances and methods
BR0112124B1 (pt) * 2000-07-05 2011-06-14 pà de celulose, processo para produzir um pà de celulose, excipiente, e, produto moldado.
WO2002022172A2 (fr) * 2000-09-14 2002-03-21 University Of Iowa Research Foundation Cellulose en poudre ou en microfibrilles
TWI290471B (en) * 2000-11-06 2007-12-01 Asahi Kasei Corp Cellulosic particles for pharmaceutical preparations
US8071133B2 (en) * 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
WO2004073729A1 (fr) * 2003-02-21 2004-09-02 Translational Research Ltd. Compositions destinees a l'administration nasale d'un medicament
US7278982B2 (en) 2003-03-27 2007-10-09 Bioactis Limited Powder medicine applicator for nasal cavity
US20050287208A1 (en) * 2004-06-22 2005-12-29 University Of Iowa Research Foundation Cross-linked powered/microfibrillated cellulose II
WO2006016530A1 (fr) * 2004-08-10 2006-02-16 Translational Research, Ltd. Composition transnasale dont l’action est immédiate et l’absorbabilité est élevée
TWI313278B (en) * 2005-04-22 2009-08-11 Asahi Kasei Chemicals Corp Porous cellulose agglomerate and molded composition thereof
AU2006318815B2 (en) 2005-11-17 2010-08-19 Novartis Ag Pharmaceutical composition
JP4841564B2 (ja) * 2005-12-06 2011-12-21 旭化成ケミカルズ株式会社 高速直接打錠による錠剤の製造方法
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (fr) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Compositions d'inhibiteurs de la DPP IV
CA2810839A1 (fr) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphes
JP5415769B2 (ja) 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
WO2008127794A2 (fr) 2007-04-13 2008-10-23 Dow Global Technologies Inc. Matière granulaire pour formes de dosage
US8367115B2 (en) * 2007-08-27 2013-02-05 Asahi Kasei Chemicals Corporation Process for production of crystalline cellulose and tablets containing granules
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
WO2009142255A1 (fr) * 2008-05-21 2009-11-26 旭化成ケミカルズ株式会社 Poudre de cellulose ayant un excellent effet de prévention de la ségrégation et compositions de celle-ci
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
WO2010097243A2 (fr) 2009-02-27 2010-09-02 Krka, D. D., Novo Mesto Procédé de fabrication de formes posologiques orales de solifénacine et de ses sels pharmaceutiquement acceptables
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US8827946B2 (en) * 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US8992987B2 (en) 2011-04-06 2015-03-31 Dow Global Technologies Llc Polysaccharide derivatives and dosage forms
US9592199B2 (en) 2012-05-31 2017-03-14 Asahi Kasei Chemicals Corporation Cellulose powder
JP6216074B2 (ja) 2014-08-12 2017-10-18 旭化成株式会社 微小セルロース粉末
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (fr) *
US3146168A (en) * 1962-04-10 1964-08-25 Fmc Corp Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
JPS5429566B2 (fr) * 1974-09-13 1979-09-25
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho

Also Published As

Publication number Publication date
NL7803869A (nl) 1978-10-17
IT7822237A0 (it) 1978-04-12
GB1603533A (en) 1981-11-25
PH14128A (en) 1981-02-26
FR2387040A1 (fr) 1978-11-10
IE780729L (en) 1978-10-13
DK159978A (da) 1978-10-14
PH15398A (en) 1982-12-23
FR2387040B1 (fr) 1983-01-28
US4159345A (en) 1979-06-26
AU3279578A (en) 1979-08-02
DE2816055A1 (de) 1978-10-26
AU508480B2 (en) 1980-03-20
IT1095577B (it) 1985-08-10
IE46720B1 (en) 1983-09-07

Similar Documents

Publication Publication Date Title
LU79423A1 (fr) Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline
IT1109273B (it) Procedimento per preparare composizioni farmaceutiche a base di amossicillina
RO79065A (fr) Procede de preparation des derives de l'acide d(k-phenoxypropionoque)
BE863883A (fr) Procede de preparation de derives de la pyrrolidine
BE867326A (fr) Procede de preparation de 1,2-polybutadiene
PT64907B (fr) Procede de preparation d'une formulation a activite retarde
BE842004A (fr) Procede de preparation de mannitol a partir de glucose
BE861112A (fr) Procede de preparation de 2-nitrate de 1,4:3,6-dianhydro-d-glucitol
BE865661A (fr) Procede de preparation de 3-alkyl-butene-1-als
LU80459A1 (fr) Procede de preparation de compositions tensio-actives cationiques
PT76853B (fr) Procede de preparation de compositions pharmaceutiques a base de xylosides et lyxosides de base puriques et pyrimidiques
BE865201A (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
FR2325665A1 (fr) Procede de preparation de telomeres a base d'iodures de perfluoro-alkyle
PT68192A (en) Process for obtaining pharmaceutical compositions
BE865532A (fr) Procede de preparation de 2,2-dimethylolalcanals
FR2330765A1 (fr) Composition comprimee a base de levure et procede de sa preparation
RO75382A (fr) Procede pour la preparation des composes 1-halogene-1-propyne-3-oli
BE863542A (fr) Procede de preparation de mousses rigides de polyurethannes
FR2325692A1 (fr) Procede de preparation de poudres de poly(amide-imides)
GB1545629A (en) Process for preparing diaminodikto-,diaminodihydroxy-aminohydroxydiketo-,dihydroxyketimino-and diketo dihydroxy-hydronaphthacene derivatives
PT68138A (fr) Procede de preparation de methoxy-2 benzamides
SE7803456L (sv) Forfarande for framstellning av en farmaceutisk komposition
LU80262A1 (fr) Procede de preparation de 10,11-dihydro-5h-dibenzo(a,d)cycloheptene-5,10-imines substituees en position 5
HU179217B (en) Process for preparing a pharmaceutical composition for sensibilisation
BE872842A (fr) Procede de preparation de derives de 1-hydroxyaporphine